Evan Hegarty started out in helping human disease in Alzheimer's and moved his way up to co-found Newormics. Newormics offers toxicology services using their advanced microfluidic devices for high-throughput and high-content screening of small animal models and 3D tissue organoids. Evan talks about their exciting new project in testing a full chemical library of known toxicities from the NIH. Their goal is to reduce animal testing by using their technology, which will be a huge accomplishment. Almost as big as playing a show for over 20 thousand people in Austin with his band. ;)
If you missed it, check out their webinar on their early uses of their technology.
Newormics is a SLAS2021 Ignite Award finalist and participated in Innovation AveNEW at SLAS2021 Digital.
Upcoming SLAS Events:
SLAS Building Biology in 3D Symposium
SLAS Europe 2024 Conference and Exhibition